Financhill
Back

Monopar Therapeutics Stock Predictions

Monopar Therapeutics Stock Forecast

  • Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 558.6% based on the past 5 years of stock performance.
  • Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Monopar Therapeutics Stock Undervalued?
    The current Monopar Therapeutics [MNPR] share price is $44.68. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Monopar Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 558.6% based on the past 5 years of stock performance.

Monopar Therapeutics Stock Rating

Buy
65
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics overpriced?

  • Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Monopar Therapeutics Stock Price History

Is MNPR stock going to rise?

  • The current trend is moderately bullish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com

52-Week Data

52-Week High:
54.30
52-Week Low:
1.65

Prediction Charts

Market Cap:
235.8M
Price in USD:
44.68
Volume:
58.8K
Beta:
1.33

Technical Analysis

SMA50:
31.43
SMA100:
21.73
SMA200:
12.52
52-Wk Change:
2607.06%

Stock Predictions

  • Is Monopar Therapeutics stock public?
    Yes, Monopar Therapeutics is a publicly traded company.
  • What is the Monopar Therapeutics stock quote today?
    The Monopar Therapeutics stock price is 44.68 USD today.
  • How to buy Monopar Therapeutics stock online?
    You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-27 40.55 33.52 45.27 31.00
Jan-28 34.80 41.82 42.39 34.50
Jan-29 42.02 38.80 42.02 34.41
Jan-30 39.50 42.50 42.50 37.20
Jan-31 42.93 43.94 44.86 38.90
Feb-3 41.45 43.55 44.36 38.90
Feb-4 43.50 48.00 49.98 41.83
Feb-5 48.93 48.77 51.48 45.95
Feb-6 48.81 47.11 51.22 43.44
Feb-7 46.16 48.46 49.22 46.16
Feb-10 48.50 51.89 54.30 47.81
Feb-11 52.12 51.33 52.25 48.43
Feb-12 51.21 50.52 51.80 49.05
Feb-13 50.38 44.68 50.38 43.97

Monopar Therapeutics Earnings

Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Monopar Therapeutics Forecast Revenue Growth

Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.

* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.